Related Experiment Video
Updated: Aug 11, 2026
08:47
Spectral Confocal Imaging of Fluorescently tagged Nicotinic Receptors in Knock-in Mice with Chronic Nicotine Administration
Published on: February 10, 2012
Pharmacological approaches to smoking cessation
I Mitrouska1, I Bouloukaki, N M Siafakas
1Department of Thoracic Medicine, University General Hospital, Medical School of the University of Crete, 71110 Heraklion, Crete, Greece. mitrouska@med.uoc.gr
Pulmonary Pharmacology & Therapeutics
|February 25, 2006
Summary
Smoking remains a global health crisis, with nicotine addiction driving the habit. While some treatments exist, new, more effective drugs are urgently needed to combat widespread smoking.
Area of Science:
- Public Health
- Addiction Medicine
- Pharmacology
Background:
- Smoking is a leading cause of preventable mortality worldwide, affecting over 1.1 billion people.
- Nicotine addiction is the primary driver of smoking, making cessation challenging for many.
- Existing pharmacological treatments for nicotine addiction, such as nicotine replacement therapy and bupropion, have limitations.
Purpose of the Study:
- To review the current landscape of smoking cessation treatments.
- To highlight the unmet need for more effective pharmacological interventions.
- To explore potential alternative pharmacotherapies for difficult-to-treat smokers.
Main Methods:
- Literature review of smoking cessation pharmacotherapies.
- Analysis of approved and experimental treatments for nicotine addiction.
- Examination of off-label drug use for smoking cessation.
Main Results:
- Nicotine replacement therapy and bupropion are approved but not universally effective.
- A significant proportion of smokers struggle to quit with current standard treatments.
- Investigational agents and repurposed drugs show potential for specific subgroups.
Conclusions:
- Despite available therapies, a substantial public health challenge persists due to smoking.
- There is a critical need for novel pharmacological agents to improve smoking cessation rates globally.
- Further research into alternative treatments is essential to address the smoking panepidemic.
Related Concept Videos
01:23Drugs Acting on Autonomic Ganglia: Stimulants
Ganglionic stimulants activate NM nicotinic receptors in autonomic ganglia, falling into two categories: nicotine mimetics [e.g., lobeline, dimethylpiperazine, tetramethylammonium] and muscarinic receptor agonists [e.g., muscarine, methacholine]. The first category's action is rapid and blocked by nicotinic receptor antagonists, while the second category's action is delayed and blocked by atropine-like agents. Nicotine, an alkaloid, affects the heart rate by stimulating sympathetic or...
01:27CNS Depressants: Alcohol and Nicotine
Ethanol, a clear colorless alcohol, has been consumed by humans for millennia, but its effects on the body are far from benign. At lower doses, it induces decreased inhibitions and loquaciousness, leading to its social appeal. However, it can cause severe consequences at higher doses, such as coma and respiratory depression, due to its zero-order elimination kinetics. Chronic ethanol abuse wreaks havoc on multiple organ systems, particularly the CNS and the liver. Abrupt cessation of ethanol...
01:23Antidepressant Drugs: MAOIs and Other Agents
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
01:29Chronic Obstructive Pulmonary Disease-V: Management
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
01:17Drug Dependence
Medications are typically administered to achieve therapeutic effects. Some drugs can modify an individual's mood and perception, frequently resulting in various enjoyable experiences. However, this can result in drug dependency, a condition marked by continuous drug use despite potential negative consequences. Drug dependency primarily falls into two categories: psychological and physical dependence. Psychological dependence occurs when the pleasurable feelings induced by the drug...
01:25Adrenergic Agonists: Indirect-Acting Agents
Indirect-acting adrenergic agonists potentiate the effects of endogenous catecholamines through different mechanisms without directly binding to adrenoceptors.
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral bioavailability, and...
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral bioavailability, and...